Cheong-Hee Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cheong-Hee Chang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Wei Li
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202
2 shared publicationsDipak R. Patel
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
1 shared publicationGaio Hangoc
Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publicationJae-Seung Park
Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publication- Kevin M. Nickerson
Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
1 shared publication M. Hanief Sofi
Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 shared publication
Latest Publications
- Open Access
- 20 June 2005
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 201 (12) , 1899-1903
Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells
Interleukin (IL)-4 is known to be the most potent cytokine that can initiate Th2 cell differentiation. Paradoxically, IL-4 instructs dendritic cells (DCs) to promote Th1 cell differentiation. We investigated the mechanisms by which IL-4 directs CD4 T cells toward the Th1 cell lineage. Our study demonstrates that the IL-4–mediated induction of Th1 cell differentiation requires IL-10 production by DCs. IL-4 treatment of DCs in the presence of lipopolysaccharide or CpG resulted in decreased production of IL-10, which was accompanied by enhanced IL-12 production. In IL-10–deficient DCs, the level of IL-12 was greatly elevated and, more importantly, the ability of IL-4 to up-regulate IL-12 was abrogated. Interestingly, IL-4 inhibited IL-10 production by DCs but not by B cells. The down-regulation of IL-10 gene expression by IL-4 depended on Stat6 and was at least partly caused by decreased histone acetylation of the IL-10 promoter. These data indicate that IL-4 plays a key role in inducing Th1 cell differentiation by instructing DCs to produce less IL-10.
- 20 June 2005
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 201 (12) , 1899-1903
Open AccessInterleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells
Interleukin (IL)-4 is known to be the most potent cytokine that can initiate Th2 cell differentiation. Paradoxically, IL-4 instructs dendritic cells (DCs) to promote Th1 cell differentiation. We investigated the mechanisms by which IL-4 directs CD4 T cells toward the Th1 cell lineage. Our study demonstrates that the IL-4–mediated induction of Th1 cell differentiation requires IL-10 production by DCs. IL-4 treatment of DCs in the presence of lipopolysaccharide or CpG resulted in decreased production of IL-10, which was accompanied by enhanced IL-12 production. In IL-10–deficient DCs, the level of IL-12 was greatly elevated and, more importantly, the ability of IL-4 to up-regulate IL-12 was abrogated. Interestingly, IL-4 inhibited IL-10 production by DCs but not by B cells. The down-regulation of IL-10 gene expression by IL-4 depended on Stat6 and was at least partly caused by decreased histone acetylation of the IL-10 promoter. These data indicate that IL-4 plays a key role in inducing Th1 cell differentiation by instructing DCs to produce less IL-10.
- 31 January 2005
- Published by Elsevier in Cellular Immunology
- Vol. 233 (1) , 30-40
Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus
- 31 January 2005
- Published by Elsevier in Cellular Immunology
- Vol. 233 (1) , 30-40
Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus
- Open Access
- 1 October 2003
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 15 (10) , 1195-1205
Phosphorylation of class II transactivator regulates its interaction ability and transactivation function
The MHC class II transactivator (CIITA) plays a central role in adaptive immune responses by controlling the expression of MHC class II genes. CIITA binds DNA‐binding proteins and co‐activator proteins to form an enhanceosome complex necessary for MHC class II gene expression. Here we demonstrate that CIITA interactions depend upon the phosphorylation status of CIITA. Hyper‐phosphorylated CIITA interacts with co‐activator p300, RFX5 and CIITA itself, which in turn results in induction of MHC class II promoter activity. Moreover, the C‐terminal region of CIITA containing leucine‐rich repeats (LRR) is a regulatory domain for CIITA self‐association and LRR binding to CIITA is negatively regulated by phosphorylation. cAMP‐dependent protein kinase (PKA) phosphorylates CIITA, and serine residues residing in a region between the proline/serine/threonine‐rich domain and the GTP‐binding domain are phosphorylated by PKA in vitro. The maximum transactivation potential of CIITA requires PKA phosphorylation as demonstrated by reduced transactivation activities of the mutant bearing substitutions of serine residues at the PKA site.
- 1 October 2003
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 15 (10) , 1195-1205
Open AccessPhosphorylation of class II transactivator regulates its interaction ability and transactivation function
The MHC class II transactivator (CIITA) plays a central role in adaptive immune responses by controlling the expression of MHC class II genes. CIITA binds DNA‐binding proteins and co‐activator proteins to form an enhanceosome complex necessary for MHC class II gene expression. Here we demonstrate that CIITA interactions depend upon the phosphorylation status of CIITA. Hyper‐phosphorylated CIITA interacts with co‐activator p300, RFX5 and CIITA itself, which in turn results in induction of MHC class II promoter activity. Moreover, the C‐terminal region of CIITA containing leucine‐rich repeats (LRR) is a regulatory domain for CIITA self‐association and LRR binding to CIITA is negatively regulated by phosphorylation. cAMP‐dependent protein kinase (PKA) phosphorylates CIITA, and serine residues residing in a region between the proline/serine/threonine‐rich domain and the GTP‐binding domain are phosphorylated by PKA in vitro. The maximum transactivation potential of CIITA requires PKA phosphorylation as demonstrated by reduced transactivation activities of the mutant bearing substitutions of serine residues at the PKA site.